Cutler Group LP Vertex Pharmaceuticals Inc Transaction History

Cutler Group LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$273.83 - $305.53 $41,074 - $45,829	-150 Reduced 42.86%	200 $57,000
Q2 2022 Aug 04, 2022	SELL	$234.96 - $292.55 $397,082 - $494,409	-1,690 Reduced 82.84%	350 $98,000
Q4 2021 Jan 18, 2022	SELL	$177.01 - $223.45 $284,986 - $359,754	-1,610 Reduced 44.11%	2,040 $447,000
Q2 2021 Jul 19, 2021	SELL	$187.49 - $221.1 $234,362 - $276,375	-1,250 Reduced 25.51%	3,650 $735,000
Q1 2021 Apr 26, 2021	BUY	$207.02 - $241.31 $828,080 - $965,240	4,000 Added 444.44%	4,900 $1.05 Million
Q1 2020 May 07, 2020	SELL	$199.77 - $247.81 $423,512 - $525,357	-2,120 Reduced 70.2%	900 $214,000
Q4 2019 Feb 06, 2020	SELL	$166.71 - $223.91 $150,039 - $201,519	-900 Reduced 22.96%	3,020 $661,000
Q3 2019 Oct 28, 2019	SELL	$166.23 - $187.09 $66,492 - $74,836	-400 Reduced 9.26%	3,920 $664,000
Q2 2019 Aug 09, 2019	BUY	$164.61 - $190.37 $625,518 - $723,406	3,800 Added 730.77%	4,320 $792,000
Q1 2019 May 10, 2019	SELL	$163.73 - $194.7 $49,119 - $58,410	-300 Reduced 36.59%	520 $95,000
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $104,918 - $122,371	720 Added 720.0%	820 $139,000
Q1 2018 May 11, 2018	SELL	$151.6 - $177.13 $4.15 Million - $4.85 Million	-27,397 Reduced 99.64%	100 $16,000
Q4 2017 Jan 17, 2018	SELL	$137.28 - $155.55 $2.33 Million - $2.64 Million	-16,991 Reduced 38.19%	27,497 $4.12 Million
Q3 2017 Oct 17, 2017	BUY	$148.13 - $162.24 $6.59 Million - $7.22 Million	44,488	44,488 $6.76 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.